UG logo

UNITED GUARDIAN INC

UGNASDAQ
πŸ† #4481 by market capUS Equity
$6.74β–² $0.08 (+1.13%)
πŸŒ… Pre-market$6.74β–² 0.00%Regular close Β· extended-hours price shown
πŸ””
Track UG
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 1.1%
7dβ–Ό 2.6%
14dβ–Ό 2.6%
30dβ–Ό 7.4%
ytdβ–² 10.1%
1yβ–Ό 9.3%
🏦Market Cap
$31M
Small Cap
πŸ“ˆRevenue Growth (YoY)
3.2%
Slowing
πŸ“ŠGross Margin
46.9%
Healthy
πŸ’΅FCF Margin
30.3%
Strong
βš–οΈP/S Ratio
2.7x
Cheap
Otter Score
β€”
Insufficient data

Trading Snapshot

Day Range
$6.61 – $6.91
52-Week Range
$5.58 – $8.45
Volume (shares)
12,466
Avg Volume (shares)
β€”
Shares Outstanding
4.6M
Next Earnings
β€”

Fundamentals Snapshot

Annual Revenue
$11M
Last Q Revenue
$3M
P/E Ratio
12.5
P/S Ratio
2.7x
EPS (TTM)
$0.54
Dividend Yield
7.48%
Dilution (1yr)
+0.0%
UG logo

UNITED GUARDIAN INC

UG
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$11Mβ–Ό βˆ’13.4% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
47.7%β–Ό βˆ’10.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$2Mβ–Ό βˆ’38.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$2Mβ–Ό βˆ’37.1% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
4.6Mβ–² +0.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$1Mβ–Ό βˆ’$625K YoY
StockOtter Β· stockotter.space

About UNITED GUARDIAN INC

United-Guardian, Inc., operating both domestically and globally, specializes in the development, production, and distribution of a diverse range of cosmetic raw materials, pharmaceutical solutions, medical-grade lubricants, and proprietary industrial chemicals. Its extensive cosmetic ingredients catalog includes the LUBRAJEL line of water-based moisturizing and lubricating gel formulations, featuring variants such as LUBRAJEL NATURAL (derived from natural sources), LUBRAJEL MARINE, and LUBRASIL II SB (a silicone-infused LUBRAJEL formulation). Other key offerings in this category are LUBRAJEL II XD; B-122, a powdered lubricant suitable for pressed powders, eyeliners, blushes, and industrial uses; KLENSOFT, a surfactant for shampoos, shower gels, and makeup removers; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, and cleansers. For medical applications, United-Guardian provides lubricants like LUBRAJEL RR and RC, which are water-based gels specifically designed for urinary catheters. LUBRAJEL MG serves to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices. The company also offers LUBRAJEL LC and LUBRAJEL FA, specialized LUBRAJEL formulations tailored for oral care, alongside LUBRAJEL FLUID for lubricating various water-soluble products. The pharmaceutical portfolio features RENACIDIN, a prescription medication for preventing and dissolving calcifications in urethral catheters and the urinary bladder. Also included is CLORPACTIN WCS-90, an antimicrobial agent effective against infections in the urinary bladder, localized peritoneal infections, and infections affecting the eyes, ears, nose, throat, and sinuses. Industrial products comprise DESELEX, a sequestering and chelating agent vital for detergent manufacturing, and THOROCLENS, a powerful chlorine-based industrial cleaning solution. The firm also dedicates resources to research and development, primarily focusing on advancing cosmetic ingredients. Products are brought to market through a robust network of marketing partners, distributors, and wholesalers. Established in 1942, United-Guardian maintains its headquarters in Hauppauge, New York.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100
Analyst data unavailable.

Latest News & Updates